Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes
about
Urinary Biomarkers in the Assessment of Early Diabetic NephropathyRenal angiotensin-converting enzyme and blood pressure controlThe intrarenal generation of angiotensin II is required for experimental hypertensionRole of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.Translational studies on augmentation of intratubular renin-angiotensin system in hypertensionUrinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain.Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.Nonclassical renin-angiotensin system and renal function.Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetesRosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretionCircadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.Intratubular renin-angiotensin system in hypertensionRelationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patientsAngiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.Role of stimulated intrarenal angiotensinogen in hypertension.Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetesCirculating and intrarenal renin-angiotensin systems in healthy men and nonpregnant womenAugmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure.Angiotensin II blockade and renal protection.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathyTubulointerstitial disease in diabetic nephropathy.Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.Sickle cell nephropathy: challenging the conventional wisdom.Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.How the kidney hyperfiltrates in diabetes: From molecules to hemodynamics.Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes.Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children.Role of the intrarenal renin-angiotensin system in the progression of renal disease.The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients.
P2860
Q26740305-13C7EA59-69B1-4FFE-8B60-35725C83A4FBQ26827777-0B60A926-1676-40F1-B716-74E68D4B9BC3Q27025017-EED5983E-41BC-4831-A895-F389AF3B2A8FQ30429844-6255B6E4-8387-4B94-A420-305BCA635303Q33585798-B19FC931-7070-4884-B0F1-D6F1ED72CB89Q33716378-7510EB3B-3EE8-4C8E-B887-7A7C37058049Q33808763-3B13E1FE-07CB-4B20-8460-C80B1C3ED3E1Q33873530-89A0ABC2-9B42-4F54-8967-5ADF17694D76Q33902878-BDC7EF02-DD16-48BE-A3A5-8317EB1DF0E8Q33940516-CBEF6B07-1B2A-4DF1-9318-472089CD00A4Q33995050-445F9C27-EB5B-456C-9489-7A958A7586F2Q34227889-25923B17-4258-44B6-A14A-03A1C9883BC5Q34293723-3DB4E298-69F1-4E05-B770-8D1AEA6C4EFBQ34416954-FA16D730-2025-4071-B2BA-9FEF086DFC29Q34706863-3E27974C-8313-4750-934E-6878FD6D8CA6Q34715015-D38AB4E9-86E8-4369-8CCD-14B548F331D9Q34777649-D1306420-FE48-4444-A1FF-A162BF54B79CQ35179398-4FB75067-D690-40E5-B031-6DEBCC70FD3EQ35227691-617C59CB-38C9-4E41-B0D6-EFDB88C83C1DQ35528122-412320A2-F162-43A4-9F73-DA8CF5CA0414Q35663915-B864EAA5-0E28-45D1-9E66-ACC397BD081CQ35916243-48FDE69A-ACFB-49D1-BD7B-37B912466819Q36035037-27C30B55-DB22-4284-887A-AD2C63C5FC73Q36219052-CEFBAD46-6E96-4033-80CF-CD59F2DE40CAQ36236725-5B8A254D-4C2C-4DB7-8F08-CDF3F18D5BA0Q36247968-6268CFDF-D404-4DF9-ACD2-FE293D4C1450Q36449123-1B507F5A-DFB8-4DAC-9F10-45E732BE2B71Q36561841-8F03BCA0-0B6C-4E0B-8287-BBC441808901Q36600752-FA947C6C-FFE2-42D6-BDF4-7E1BE4D5FA5FQ36836004-279C1391-EF8C-4636-A987-38D035961B67Q37375567-604ED4BC-4EBB-461D-8A37-CF830EEF1A53Q37669397-21361C9B-006C-4371-970C-388BC855A349Q37740463-BD4FB3D2-B20D-43CB-81E3-209151E2B19DQ37825800-25EC4045-B82B-48D5-8AFA-5DC6606602F7Q38472971-36AA9F8B-7CF7-4D55-92EB-D0DEC309556DQ38490617-E96A03E3-F471-46A7-A924-DD005CFF5E35Q38735470-EB0C633D-997D-496F-A3A1-59D284F9E47EQ38740569-3C9742A7-551B-4E48-8734-BD33E081E846Q38886761-E34E62CB-D807-444B-AD69-0DF0E6FC7B0CQ40296770-287A2CC7-9B69-4AFD-972C-972697072316
P2860
Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased urinary angiotensino ...... patients with type 1 diabetes
@en
Increased urinary angiotensino ...... patients with type 1 diabetes.
@nl
type
label
Increased urinary angiotensino ...... patients with type 1 diabetes
@en
Increased urinary angiotensino ...... patients with type 1 diabetes.
@nl
prefLabel
Increased urinary angiotensino ...... patients with type 1 diabetes
@en
Increased urinary angiotensino ...... patients with type 1 diabetes.
@nl
P2093
P2860
P1476
Increased urinary angiotensino ...... patients with type 1 diabetes
@en
P2093
Maki Urushihara
Shoji Kagami
Toshie Saito
Yumiko Kotani
P2860
P304
P356
10.1097/MAJ.0B013E3181B90C25
P407
P577
2009-12-01T00:00:00Z